219 related articles for article (PubMed ID: 11920181)
21. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
[TBL] [Abstract][Full Text] [Related]
22. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
[TBL] [Abstract][Full Text] [Related]
23. Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation.
Soiffer RJ; Gonin R; Murray C; Robertson MJ; Cochran K; Chartier S; Cameron C; Daley J; Levine H; Nadler LM
Blood; 1993 Oct; 82(7):2216-23. PubMed ID: 7691252
[TBL] [Abstract][Full Text] [Related]
24. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
25. Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation.
Comoli P; Maccario R; Montagna D; Labirio M; Zecca M; Clementi R; Bonetti F; Locatelli F
Clin Exp Immunol; 1994 Sep; 97(3):510-6. PubMed ID: 8082308
[TBL] [Abstract][Full Text] [Related]
26. Umbilical cord blood transplantation--how, when and for whom?
Cohen Y; Nagler A
Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
[TBL] [Abstract][Full Text] [Related]
27. Changes in the pattern of TCR V beta repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans.
Lonial S; Bomberger C; Waller EK
Br J Haematol; 2001 Apr; 113(1):224-30. PubMed ID: 11328305
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
29. Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT).
Nagler A; Rabinowitz R; Rosengolts-Rat J; Condiotti R; Schlesinger M
J Hematother Stem Cell Res; 2000 Feb; 9(1):63-75. PubMed ID: 10738973
[TBL] [Abstract][Full Text] [Related]
30. Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection.
Scott I; O'Shea J; Bunce M; Tiercy JM; Argüello JR; Firman H; Goldman J; Prentice HG; Little AM; Madrigal JA
Blood; 1998 Dec; 92(12):4864-71. PubMed ID: 9845554
[TBL] [Abstract][Full Text] [Related]
31. CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A.
Eissens DN; Schaap NP; Preijers FW; Dolstra H; van Cranenbroek B; Schattenberg AV; Joosten I; van der Meer A
Leukemia; 2010 Mar; 24(3):583-91. PubMed ID: 20033055
[TBL] [Abstract][Full Text] [Related]
32. Increased proportion of HLA-class-I-specific natural killer cell receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
Tanaka J; Tutumi Y; Zhang L; Mori A; Kahata K; Toyoshima N; Ohta S; Kobayashi S; Hashino S; Asaka M; Imamura M
Acta Haematol; 2001; 105(2):89-91. PubMed ID: 11408710
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.
Keever CA; Welte K; Small T; Levick J; Sullivan M; Hauch M; Evans RL; O'Reilly RJ
Blood; 1987 Dec; 70(6):1893-903. PubMed ID: 3118990
[TBL] [Abstract][Full Text] [Related]
34. Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study.
Arima N; Nakamura F; Yabe T; Tanaka J; Fuji S; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Mori T; Kobayashi N; Hoshino T; Kato C; Kanamori H; Nakamae H; Atsuta Y; Morishima Y; Kanda Y
Biol Blood Marrow Transplant; 2016 Mar; 22(3):423-31. PubMed ID: 26456260
[TBL] [Abstract][Full Text] [Related]
35. The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions.
Sconocchia G; Lau M; Provenzano M; Rezvani K; Wongsena W; Fujiwara H; Hensel N; Melenhorst J; Li J; Ferrone S; Barrett AJ
Blood; 2005 Nov; 106(10):3666-72. PubMed ID: 16046526
[TBL] [Abstract][Full Text] [Related]
36. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
J Exp Med; 1993 Oct; 178(4):1321-36. PubMed ID: 8376937
[TBL] [Abstract][Full Text] [Related]
37. Reciprocal age related change in natural killer cell receptors for MHC class I.
Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK
Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327
[TBL] [Abstract][Full Text] [Related]
38. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
39. The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.
Kordelas L; Steckel NK; Horn PA; Beelen DW; Rebmann V
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801784
[TBL] [Abstract][Full Text] [Related]
40. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
